跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Tetralysal
Approved
STANDARD
Tetralysal
Sophartex
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b7c99c56f4db4346
Company
Sophartex
Type
Standard
Approval Details
Approval Id
b7c99c56f4db4346
Drug Approval Philippines Name
Tetralysal
Product Name
Tetralysal
Registration Number
DR-XY29605
Brand Name
Tetralysal
Generic Name
Lymecycline
Dosage Form
Capsule
Dosage Strength
300 mg
Manufacturer
Sophartex
Importer
Galderma Philippines, Inc.
Distributor
Galderma Philippines, Inc.
Issuance Date
29 May 2023
Expiry Date
29 May 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b7c99c56f4db4346
Type
Standard
Back to Philippines FDA Approvals
Tetralysal - Philippines FDA Drug Approval Details